Lifestance Health Group Inc (LFST)vsNovartis AG ADR (NVS)
LFST
Lifestance Health Group Inc
$7.41
-3.01%
HEALTHCARE · Cap: $2.94B
NVS
Novartis AG ADR
$148.38
-0.55%
HEALTHCARE · Cap: $273.77B
Smart Verdict
WallStSmart Research — data-driven comparison
Novartis AG ADR generates 3685% more annual revenue ($56.58B vs $1.49B). NVS leads profitability with a 23.9% profit margin vs 1.6%. NVS trades at a lower P/E of 20.6x. LFST earns a higher WallStSmart Score of 56/100 (C).
LFST
Buy56
out of 100
Grade: C
NVS
Hold49
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+33.6%
Fair Value
$10.44
Current Price
$7.41
$3.03 discount
Margin of Safety
-62.1%
Fair Value
$91.39
Current Price
$148.38
$56.99 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 1927.0% YoY
Conservative balance sheet, low leverage
Reasonable price relative to book value
Revenue surging 21.2% year-over-year
Mega-cap, among the largest globally
Every $100 of equity generates 35 in profit
Strong operational efficiency at 30.5%
Keeps 24 of every $100 in revenue as profit
Generating 2.9B in free cash flow
Areas to Watch
Distress zone — elevated risk
ROE of 1.6% — below average capital efficiency
1.6% margin — thin
Premium valuation, high expectations priced in
Grey zone — moderate risk
Elevated debt levels
Expensive relative to growth rate
Revenue declined 0.7%
Comparative Analysis Report
WallStSmart ResearchBull Case : LFST
The strongest argument for LFST centers on EPS Growth, Debt/Equity, Price/Book. Revenue growth of 21.2% demonstrates continued momentum.
Bull Case : NVS
The strongest argument for NVS centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 23.9% and operating margin at 30.5%.
Bear Case : LFST
The primary concerns for LFST are Altman Z-Score, Return on Equity, Profit Margin. A P/E of 128.5x leaves little room for execution misses. Thin 1.6% margins leave little buffer for downturns.
Bear Case : NVS
The primary concerns for NVS are Altman Z-Score, Debt/Equity, PEG Ratio.
Key Dynamics to Monitor
LFST profiles as a growth stock while NVS is a declining play — different risk/reward profiles.
LFST carries more volatility with a beta of 1.20 — expect wider price swings.
LFST is growing revenue faster at 21.2% — sustainability is the question.
NVS generates stronger free cash flow (2.9B), providing more financial flexibility.
Bottom Line
LFST scores higher overall (56/100 vs 49/100) and 21.2% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lifestance Health Group Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
LifeStance Health Group, Inc., provides outpatient mental health services to children, adolescents, adults and geriatrics. The company is headquartered in Scottsdale, Arizona.
Novartis AG ADR
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?